BSEOthers4d ago · 28 Aug 2026, 09:17 pm
41st Annual report for year 2025-26
Arvaya Healthcare Ltd · 524723
✦ AI SummaryResults
Arvaya Healthcare Ltd has announced its 41st Annual Report for the year 2025-26, along with the Notice of the Annual General Meeting (AGM) to be held on September 21, 2026. The report includes the audited standalone and consolidated financial statements for the year ended March 31, 2026.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern3/10
Regulatory Risk1/10
Balance Sheet Risk4/10
Liquidity Impact6/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Arvaya Healthcare Ltd - 524723 - Reg. 34 (1) Annual Report.
Attachments (1)
📄pdf
Download →
56ac5707-7a93-4a21-8b6c-d314169cf101.pdf
View document text
Date:28th August 2026
BSE Limited
Phiroze Jeejeebhoy Towers,
Dalal Street,
Mumbai – 400 001
Respected Authorities,
Sub: Annual Report for the Financial Year 2025-26 along with Notice of the Annual General Meeting
Ref: “Arvaya Healthcare Limited” (ARVAYA/524723)
Pursuant to Regulation 34(1) of the SEBI (Listing Obligations and Disclosure Requirements)
Regulations, 2015 (‘SEBI Listing Regulations’), we are enclosing herewith Annual Report and the Notice
of the Forty First Annual General Meeting (‘AGM’) of the Company for the Financial Year 2025-26, to
be held on 21 September 2026 at 3:00 p.m. (IST) through Video Conferencing.
The Notice of the AGM and the Annual Report are being dispatched electronically to those members
whose e-mail IDs are registered with the Company / Registrar and Share Transfer Agent (“RTA”)/
Depositories.
Further, pursuant to Regulation 36(1)(b) of the SEBI Listing Regulations, a physical Communication is
also being sent by the Company to those shareholders whose e-mail addresses are not registered with
the Company/RTA/ Depositories, providing them a web-link for accessing the Notice of the AGM and
Annual Report.
The Notice of the AGM and the Annual Report are also available on the Company’s website and can
be accessed at www.arvayahealth.com
The above is for your information and records please.
Thanking you,
For Arvaya Healthcare Limited
(formerly known as Bijoy Hans Limited)
Kaushal Uttam Shah
Managing Director
DIN:02175130
Date:28th August 2026
Place: Sangli
INDEX
Particulars Page Nos.
Corporate Information 2-4
Notice of Annual General Meeting 5-80
Director’s Report 81-99
Form AOC-1 and AOC-2 (Annexure A and B) 100-106
Ratio of Remuneration of Directors 107-109
Form MR-3 – Secretarial Audit Report 110-115
MD & CFO Certification and Code of Conduct Declaration 116-117
Management Discussion and Analysis Report 118-128
Corporate Governance Report 129-150
Certificate of Compliance and Non-Disqualification of Director 151-153
Standalone and Consolidate Financial Statements 154 Onwards
CORPORATE INFORMATION
BOARD OF DIRECTORS
Mr. Kaushal Uttam Shah Managing Director & Chairman
(Appointed on 26th May 2025)
Mr. Salil Sriram Shetty CEO & Executive Director
Mrs. Manali Aditya Pandit Non-Executive Independent Director
Mr. Rahul Ravindra Mayur Non-Executive Independent Director
(Appointed on 28th July 2025)
Mr. Brijesh Jugalkishor Biyani Non-Executive Independent Director
(Appointed on 28th July 2025)
Mr. Ashok Patwari Non-Executive Director
(Resigned on 4th November 2025)
Mr. Ashim Patwari Non-Executive Director
(Resigned on 4th November 2025)
Mr. Dhavalkumar Mashru Non-Executive Director
(Resigned on 4th November 2025)
Mrs. Kiran Kabra Non-Executive Director
(Appointed on 4th November 2025 and
Resigned on 24th November 2025)
Mr. Bidari Kotresh Anilkumar Executive Director
(Appointed on 4th July 2026)
KEY MANAGERIAL PERSONNEL
Mr. Ranganath Abhiram Chief Financial Officer
(Appointed on 28th July, 2025)
Mrs. Guinea Agrawal Company Secretary & Compliance Officer
(Appointed on 01st June, 2025)
Mr. Kaushal Uttam Shah Managing Director
(Appointed on 26th May, 2025)
Mrs. Manisha Agarwala Company Secretary & Compliance Officer
(Resigned on 31st May 2025)
STATUTORY AUDITOR
M/s. Rajesh Surana & Co., Chartered
Accountant, Guwahati (Firm Registration number: 325658E)
Address: Room No. # 303, Annapurna Plaza
3rd Floor, S. S. Road, Fancy Bazar
Guwahati - 781 001 (Assam)
E-mail: rajeshsurana_ca@yahoo.co.in
Mobile: 94350-16875
Resigned on 28th July, 2025
M/s. Khire Khandekar and Kirloskar
Chartered Accountants
Address: Flat No. A-3, Lara Residency,
Mayur Colony, Off Karve Road,
Kothrud, Pune – 411029
Email id: mandarkhire@gmail.com
Mobile No: 94238-71912
Appointed on 28th July, 2025
SECRETARIAL AUDITOR
M/s. SKGK & Associates LLP
Practising Company Secretary
Address: Anandi, S. No 43, Plot No. 101, Navsahyadri Society, Near Manoj Tathwade
Garden, Karve Nagar, Pune – 411 052.
Email: csgaurav@vmls.in, cspratibha@vmls.in
Contact: 9890037738
Appointed on 26th May, 2025
INTERNAL AUDITOR
Aslesh Ramchandra Parannawar,
Chartered Accountant (Membership No.: 130228)
Address: Ramleela”, Plot No. 68, T. K. Patil Housing Society, Samruddhinagar, ss – 416 416
Email id: aslesh.p@rediffmail.com
Mobile No; 9860545402
(Resigned on 20st April 2026)
M/s. G. K. Vora & Co.,
Chartered Accountants (FRN 163371W)
Address: 17/6 Rukmini Building, Velankar Nagar, Pune 411009.
Email id: vora.gaurav@gmail.com
(Appointed on 28th May, 2026)
BANKER TO THE COMPANY
IDBI Bank Union Bank of India
Bank of Baroda ICICI Bank
HDFC Bank
REGISTERED OFFICE OF THE COMPANY
Nirvana Co Working spaces, Mezzanine Floor, Itag Plaza, ABC, G S Road, Guwahati, Dispur,
Kamrup, Gmc, Assam, India, 781005
Ph: +91 7066670199
Email: compliance@arvayahealth.com
REGISTRAR & SHARE TRANSFER AGENT
Maheshwari Datamatics Pvt Ltd,
23, R. N. Mukherjee Road, 5th Floor, Kolkata 700 017
Ph: 033 22482248
Fax: 033 22435029
e-mail: mdpldc@yahoo.com
LISTED ON
BSE Limited Scrip code: 524723
NOTICE
NOTICE IS HEREBY GIVEN THAT THE 41ST ANNUAL GENERAL MEETING OF ARVAYA HEALTHCARE
LIMITED (FORMNERLY KNOWN AS BIJOY HANS LIMITED) WILL BE HELD ON MONDAY, SEPTEMBER
21, 2026 AT 03:00 PM THROUGH VIDEO CONFERENCING (‘VC)/OTHER AUDIO-VISUAL MEANS
(‘OAVM’) FACILITY TO TRANSACT THE FOLLOWING BUSINESSES:
ORDINARY BUSINESS:
1. To receive, consider and adopt the Audited Standalone Financial Statements of the Company for
the financial year ended 31 March 2026, and the reports of the Board of Directors and Auditors
thereon.
To receive, consider and adopt the audited standalone financial statements of the company for the
financial year ended 31 March 2026, together with the report of Board of Directors and Auditors
thereon as an Ordinary Resolution
2. To receive, consider and adopt the Audited Consolidated Financial Statements of the Company
for the financial year ended 31 March 2026, and the reports of the Auditors thereon.
To receive, consider and adopt the audited consolidated financial statements of the company for the
financial year ended 31 March 2026, together with the report of Board of Directors and Auditors
thereon as an Ordinary Resolution
3. To consider appointment of Mr. Kaushal Uttam Shah (DIN: 02175130) Managing Director of the
company, who retires by rotation and, being eligible, offers himself for re-appointment.
To consider and if thought fit, to pass with or without modification(s) the following Resolution as an
Ordinary Resolution:
“RESOLVED THAT pursuant to the provisions of Section 152 and all other applicable provisions, if any,
of the Companies Act, 2013 read with the Rules made thereunder and as per Articles of Association ,
Mr. Kaushal Uttam Shah (DIN:02175130), Managing Director, who holds the longest tenure and retires
by rotation at this meeting, being eligible for reappointment, has confirmed his eligibility and
willingness to accept the office, be and is hereby reappointed at the same position to hold the office
for the existing tenure based on the same terms of appointment as already approved by the Members
at the 40th Annual General Meeting of the Company.
RESOLVED FURTHER THAT the Board of Directors be and is hereby authorized to do all such acts,
deeds, matters and things as may be considered necessary, desirable and expedient for giving effect
to this resolution and/or otherwise considered by them to be in the best interest of the Company
including fixation of their remuneration and reimbursement of out-of-pocket expenses incurred in
connection hereto.”
SPECIAL BUSINESS:
ITEM NO. 4 - APPROVAL FOR MATERIAL RELATED PARTY TRANSACTION (S) UNDER SECTION 188 OF
THE COMPANIES ACT, 2013 AND REGULATION 23 OF THE SEBI (LISTING OBLIGATIONS AND
DISCLOSURE REQUIREMENTS), 2015:
To consider and if thought fit, to pass, with or without modification(s), the following resolution as an
Ordinary Resolution:
“RESOLVED THAT pursuant to the provisions of Section 188 and other applicable provisions of the
Companies Act, 2013 (“the
[Showing first 8,000 characters — download PDF for full document]